» Articles » PMID: 9551389

Genetic Studies into Inherited and Sporadic Hemolytic Uremic Syndrome

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 1998 Apr 29
PMID 9551389
Citations 158
Authors
Affiliations
Soon will be listed here.
Abstract

Hemolytic uremic syndrome (HUS) in adults carries a high morbidity and mortality, and its cause remains unknown despite many theories. Although familial HUS is rare, it affords a unique opportunity to elucidate underlying mechanisms that may have relevance to acquired HUS. We have undertaken a genetic linkage study based on a candidate gene approach. A common area bounded by the markers D1S212 and D1S306, a distance of 26 cM located at 1q32 segregated with the disease (Z max 3.94). We demonstrate that the gene for factor H lies within the region. Subsequent mutation analysis of the factor H gene has revealed two mutations in patients with HUS. In an individual with the sporadic/relapsing form of the disease we have found a mutation comprising a deletion, subsequent frame shift and premature stop codon leading to half normal levels of serum factor H. In one of the three families there is a point mutation in exon 20 causing an arginine to glycine change, which is likely to alter structure and hence function of the factor H protein. Factor H is a major plasma protein that plays a critical regulatory role in the alternative pathway of complement activation. In light of these findings and previous reports of HUS in patients with factor H deficiency, we postulate that abnormalities of factor H may be involved in the etiology of HUS.

Citing Articles

Atypical hemolytic uremic syndrome: genetically-based insights into pathogenesis through an analysis of the complement regulator CD46.

Wu X, Liszewski M, Java A, Atkinson J Ann Blood. 2025; 8.

PMID: 39949759 PMC: 11824723. DOI: 10.21037/aob-22-40.


Annual trends in atypical haemolytic uremic syndrome management in Japan and factors influencing early diagnosis and treatment: a retrospective study.

Tatematsu Y, Imaizumi T, Michihata N, Kato N, Kumazawa R, Matsui H Sci Rep. 2024; 14(1):18265.

PMID: 39107421 PMC: 11303750. DOI: 10.1038/s41598-024-68736-6.


The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome.

Avdonin P, Blinova M, Generalova G, Emirova K, Avdonin P Biomolecules. 2024; 14(1).

PMID: 38254639 PMC: 10813406. DOI: 10.3390/biom14010039.


Genetic investigation of Nordic patients with complement-mediated kidney diseases.

Rydberg V, Aradottir S, Kristoffersson A, Svitacheva N, Karpman D Front Immunol. 2023; 14:1254759.

PMID: 37744338 PMC: 10513385. DOI: 10.3389/fimmu.2023.1254759.


Atypical hemolytic uremic syndrome in the era of terminal complement inhibition: an observational cohort study.

Brocklebank V, Walsh P, Smith-Jackson K, Hallam T, Marchbank K, Wilson V Blood. 2023; 142(16):1371-1386.

PMID: 37369098 PMC: 10651868. DOI: 10.1182/blood.2022018833.